229 related articles for article (PubMed ID: 12482756)
21. The forkhead transcription factor FOXO4 induces the down-regulation of hypoxia-inducible factor 1 alpha by a von Hippel-Lindau protein-independent mechanism.
Tang TT; Lasky LA
J Biol Chem; 2003 Aug; 278(32):30125-35. PubMed ID: 12761217
[TBL] [Abstract][Full Text] [Related]
22. Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor.
Coleman ML; McDonough MA; Hewitson KS; Coles C; Mecinovic J; Edelmann M; Cook KM; Cockman ME; Lancaster DE; Kessler BM; Oldham NJ; Ratcliffe PJ; Schofield CJ
J Biol Chem; 2007 Aug; 282(33):24027-38. PubMed ID: 17573339
[TBL] [Abstract][Full Text] [Related]
23. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor.
Lando D; Peet DJ; Gorman JJ; Whelan DA; Whitelaw ML; Bruick RK
Genes Dev; 2002 Jun; 16(12):1466-71. PubMed ID: 12080085
[TBL] [Abstract][Full Text] [Related]
24. Asparagine and aspartate hydroxylation of the cytoskeletal ankyrin family is catalyzed by factor-inhibiting hypoxia-inducible factor.
Yang M; Ge W; Chowdhury R; Claridge TD; Kramer HB; Schmierer B; McDonough MA; Gong L; Kessler BM; Ratcliffe PJ; Coleman ML; Schofield CJ
J Biol Chem; 2011 Mar; 286(9):7648-60. PubMed ID: 21177872
[TBL] [Abstract][Full Text] [Related]
25. Dynamic, site-specific interaction of hypoxia-inducible factor-1alpha with the von Hippel-Lindau tumor suppressor protein.
Yu F; White SB; Zhao Q; Lee FS
Cancer Res; 2001 May; 61(10):4136-42. PubMed ID: 11358837
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide donor, (+/-)-S-nitroso-N-acetylpenicillamine, stabilizes transactive hypoxia-inducible factor-1alpha by inhibiting von Hippel-Lindau recruitment and asparagine hydroxylation.
Park YK; Ahn DR; Oh M; Lee T; Yang EG; Son M; Park H
Mol Pharmacol; 2008 Jul; 74(1):236-45. PubMed ID: 18426857
[TBL] [Abstract][Full Text] [Related]
27. Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex.
Maynard MA; Qi H; Chung J; Lee EH; Kondo Y; Hara S; Conaway RC; Conaway JW; Ohh M
J Biol Chem; 2003 Mar; 278(13):11032-40. PubMed ID: 12538644
[TBL] [Abstract][Full Text] [Related]
28. The role of iron and 2-oxoglutarate oxygenases in signalling.
Hewitson KS; McNeill LA; Elkins JM; Schofield CJ
Biochem Soc Trans; 2003 Jun; 31(Pt 3):510-5. PubMed ID: 12773146
[TBL] [Abstract][Full Text] [Related]
29. von Hippel-Lindau protein adjusts oxygen sensing of the FIH asparaginyl hydroxylase.
Li SH; Chun YS; Lim JH; Huang LE; Park JW
Int J Biochem Cell Biol; 2011 May; 43(5):795-804. PubMed ID: 21316481
[TBL] [Abstract][Full Text] [Related]
30. Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation.
Masson N; Willam C; Maxwell PH; Pugh CW; Ratcliffe PJ
EMBO J; 2001 Sep; 20(18):5197-206. PubMed ID: 11566883
[TBL] [Abstract][Full Text] [Related]
31. MYPT1, the targeting subunit of smooth-muscle myosin phosphatase, is a substrate for the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH).
Webb JD; Murányi A; Pugh CW; Ratcliffe PJ; Coleman ML
Biochem J; 2009 May; 420(2):327-33. PubMed ID: 19245366
[TBL] [Abstract][Full Text] [Related]
32. Regulation of the HIF pathway: enzymatic hydroxylation of a conserved prolyl residue in hypoxia-inducible factor alpha subunits governs capture by the pVHL E3 ubiquitin ligase complex.
Mole DR; Pugh CW; Ratcliffe PJ; Maxwell PH
Adv Enzyme Regul; 2002; 42():333-47. PubMed ID: 12123724
[No Abstract] [Full Text] [Related]
33. Combination of multiple alignment analysis and surface mapping paves a way for a detailed pathway reconstruction--the case of VHL (von Hippel-Lindau) protein and angiogenesis regulatory pathway.
Sikora S; Godzik A
Protein Sci; 2004 Mar; 13(3):786-96. PubMed ID: 14767077
[TBL] [Abstract][Full Text] [Related]
34. The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis.
Pugh CW; Ratcliffe PJ
Semin Cancer Biol; 2003 Feb; 13(1):83-9. PubMed ID: 12507560
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia-inducible factor 1 (HIF-1) pathway.
Semenza GL
Sci STKE; 2007 Oct; 2007(407):cm8. PubMed ID: 17925579
[TBL] [Abstract][Full Text] [Related]
36. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function.
Stebbins CE; Kaelin WG; Pavletich NP
Science; 1999 Apr; 284(5413):455-61. PubMed ID: 10205047
[TBL] [Abstract][Full Text] [Related]
37. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.
Epstein AC; Gleadle JM; McNeill LA; Hewitson KS; O'Rourke J; Mole DR; Mukherji M; Metzen E; Wilson MI; Dhanda A; Tian YM; Masson N; Hamilton DL; Jaakkola P; Barstead R; Hodgkin J; Maxwell PH; Pugh CW; Schofield CJ; Ratcliffe PJ
Cell; 2001 Oct; 107(1):43-54. PubMed ID: 11595184
[TBL] [Abstract][Full Text] [Related]
38. The facial triad in the α-ketoglutarate dependent oxygenase FIH: A role for sterics in linking substrate binding to O
Hangasky JA; Taabazuing CY; Martin CB; Eron SJ; Knapp MJ
J Inorg Biochem; 2017 Jan; 166():26-33. PubMed ID: 27815979
[TBL] [Abstract][Full Text] [Related]
39. Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1 alpha.
Elkins JM; Hewitson KS; McNeill LA; Seibel JF; Schlemminger I; Pugh CW; Ratcliffe PJ; Schofield CJ
J Biol Chem; 2003 Jan; 278(3):1802-6. PubMed ID: 12446723
[TBL] [Abstract][Full Text] [Related]
40. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
